Fortem Financial Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,530
| Closed | -$387K | – | 178 |
|
|
2021
Q1 | $387K | Sell |
2,530
-82
| -3% | -$12.5K | 0.22% | 120 |
|
|
2020
Q4 | $408K | Sell |
2,612
-100
| -4% | -$15.6K | 0.24% | 103 |
|
|
2020
Q3 | $310K | Sell |
2,712
-8,393
| -76% | -$959K | 0.22% | 113 |
|
|
2020
Q2 | $1.25M | Buy |
11,105
+342
| +3% | +$38.4K | 0.96% | 34 |
|
|
2020
Q1 | $966K | Sell |
10,763
-2,656
| -20% | -$238K | 0.88% | 41 |
|
|
2019
Q4 | $1.45M | Sell |
13,419
-3
| -0% | -$324 | 1.08% | 38 |
|
|
2019
Q3 | $1.32M | Buy |
+13,422
| New | +$1.32M | 1.12% | 41 |
|